The aim of the current research is to clarify the molecular mechanisms of PCBP1 in upregulating TPM3 expression, providing a potential therapeutic target for the treatment of esophageal squamous cell carcinoma. Here, PCBP1 is linked to esophageal squamous cell carcinoma.